Vanguard Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Vanguard Capital Management's MDT Position: Q3 2026 in Review
Vanguard Capital Management reduced its Medtronic (MDT) stake by 0.08% in Q3 2026, selling an estimated $5.65M and leaving 83,752,662 shares worth $7.23B. The position accounts for 0.15% of the portfolio, ranked #105.
Vanguard Capital Management first reported a position in MDT in Q1 2026 and has held it in 3 quarters since. 2,206 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Vanguard Capital Management held 83,752,662 shares of Medtronic worth $7.23B as of Q3 2026.
- Vanguard Capital Management sold 64,073 Medtronic shares in Q3 2026, an estimated $5.65M.
- Medtronic made up 0.15% of Vanguard Capital Management's portfolio in Q3 2026, its #105 holding.
- Vanguard Capital Management first reported a position in Medtronic in Q1 2026 and has held it in 3 quarters since.
- 2,206 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.